Live price temporarily unavailable.
HeartBeam (BEAT) is a Health Care company. Latest news and coverage below.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Operating income | −$788.0K | −$2.29M | −$13.0M | −$15.3M | −$19.9M | −$21.1M |
| Net income | −$1.07M | −$4.43M | −$13.0M | −$14.6M | −$19.4M | −$21.0M |
| EPS (diluted) | −$0.29 | −$1.03 | −$1.59 | −$0.72 | −$0.73 | −$0.62 |
| Balance sheet | ||||||
| Cash and equivalents | $24.0K | $13.2M | $3.59M | $16.2M | $2.38M | $4.38M |
| Total assets | $51.0K | $14.0M | $4.04M | $17.1M | $3.28M | $5.84M |
| Total liabilities | $4.84M | $588.0K | $1.67M | $1.19M | $1.62M | $3.24M |
| Shareholders' equity | −$4.79M | $13.4M | $2.37M | $15.9M | $1.65M | $2.60M |
| Cash flow | ||||||
| Operating cash flow | −$600.0K | −$3.23M | −$9.95M | −$12.1M | −$14.5M | −$14.0M |
| Capital expenditure | — | — | $0 | $256.0K | $201.0K | $600.0K |
| Free cash flow | — | — | −$9.95M | −$12.3M | −$14.7M | −$14.6M |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$5.07M | −$4.94M | −$5.50M | −$5.04M | −$5.29M | −$5.31M | −$4.72M | −$5.09M |
| Net income | −$4.98M | −$4.91M | −$5.48M | −$4.97M | −$5.25M | −$5.30M | −$4.70M | −$5.04M |
| EPS (diluted) | −$0.19 | −$0.18 | −$0.18 | −$0.15 | −$0.15 | −$0.14 | −$0.12 | −$0.10 |
| Balance sheet | ||||||||
| Cash and equivalents | $5.77M | $2.38M | $4.39M | $3.26M | $1.86M | $4.38M | $2.04M | $8.72M |
| Total assets | $6.66M | $3.28M | $9.11M | $5.98M | $2.88M | $5.84M | $3.93M | $10.6M |
| Total liabilities | $1.86M | $1.62M | $1.58M | $1.80M | $2.47M | $3.24M | $3.29M | $2.46M |
| Shareholders' equity | $4.80M | $1.65M | $7.53M | $4.18M | $406.0K | $2.60M | $635.0K | $8.18M |
| Cash flow | ||||||||
| Operating cash flow | −$3.31M | −$4.15M | −$4.48M | −$3.44M | −$3.16M | −$2.91M | −$3.61M | −$3.34M |
| Capital expenditure | $103.0K | $0 | $0 | $102.0K | $82.0K | $416.0K | $246.0K | $249.0K |
| Free cash flow | −$3.41M | −$4.15M | −$4.48M | −$3.55M | −$3.24M | −$3.32M | −$3.86M | −$3.59M |
From HeartBeam's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →